2026 Q1 -tulosraportti
10 päivää sitten
‧54 min
0,60 NOK/osake
Viimeisin osinko
1,01%Tuotto/v
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 76 | - | - | ||
| 9 | - | - | ||
| 14 | - | - | ||
| 1 | - | - | ||
| 20 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 9.7. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
2025 Q4 -tulosraportti 11.2. | ||
2025 Q3 -tulosraportti 23.10.2025 | ||
2025 Q2 -tulosraportti 10.7.2025 | ||
2025 Q1 -tulosraportti 7.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·3 päivää sittenUgh ugh- DnB as a major owner, shares they should not own, shares they are going to sell, shares forcibly taken from Vatne. This will be ugly Flagging notification Gentian Diagnostics DNB Bank ASA has taken over ownership of 100% of the shares in Vatne Equity AS, which as of May 12, 2026, owns 2,110,224 shares in Gentian Diagnostics ASA ("Gentian") The company's ownership interest and voting rights, corresponding to 13.65% of outstanding shares in Gentian, are therefore considered indirectly controlled by DNB Bank ASA in accordance with the Securities Trading Act § 4-2 (consolidation rules) and the acquisition was triggered by enforcement of pledge as a result of a breach of loan terms related to a secured loan.·1 päivä sitten · MuokattuHere you have it in black and white. There will be a sell-off here- stay away DNB on Gentian shares: Normally not a long-term owner On Wednesday it became known that DNB has taken over the shares in investor Runar Vatne's equity investment company Vatne Equity. Through this company, Vatne was the largest owner in Gentian Diagnostics. These shares are now owned by DNB after the bank exercised a pledge. With this, DNB has become the largest shareholder in Gentian, but it is far from certain that it will remain so. – The bank normally does not have a strategy of being a long-term owner in such companies.
6.5.6.5.Expecting "org annonuncements" related to NT-proBT project failure.
·17.3. · MuokattuIs this heading up from a double bottom formation here now? The technical risk is arguably relatively low as the last bottoms were also at the level of previous support. In addition, it is fundamentally positive that the company has the financial capacity to pay dividends.
·19.2. · MuokattuGood to get a bit more turnover in the share, almost 4 million today is quite a lot for Gentian. Not just anyone either. Forced sale? Gentian Diagnostics: CTO buys shares, companies pull out today 10:50 AM ∙ News summary (AI) Gentian Diagnostics has recently experienced significant changes in its ownership structure. The company's Chief Technology Officer (CTO), Frank Frantzen, showed confidence by increasing his personal stake through a significant share purchase. At the same time, two investment companies, SKØIEN AS and DUKAT AS, are no longer listed among the company's shareholders, which indicates a sale of their holdings. CTO Frank Frantzen bought 3,115 shares in Gentian Diagnostics at an average price of NOK 40.0 per share. After this transaction, CTO Frank Frantzen now owns a total of 23,115 shares and 50,000 options in the company. The investment company SKØIEN AS has left the list of Gentian Diagnostics' shareholders. https://e24.no/boers-og-finans/i/kw2Q29/ny-smell-for-investor-tore-aksel-voldberg-selskapets-aksjekapital-er-tapt
·13.2.Not long ago, an analyst on Hegnar-TV highlighted this stock as the best case this year. The price was then at 58 kr.. I have at least bought some today.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
10 päivää sitten
‧54 min
0,60 NOK/osake
Viimeisin osinko
1,01%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·3 päivää sittenUgh ugh- DnB as a major owner, shares they should not own, shares they are going to sell, shares forcibly taken from Vatne. This will be ugly Flagging notification Gentian Diagnostics DNB Bank ASA has taken over ownership of 100% of the shares in Vatne Equity AS, which as of May 12, 2026, owns 2,110,224 shares in Gentian Diagnostics ASA ("Gentian") The company's ownership interest and voting rights, corresponding to 13.65% of outstanding shares in Gentian, are therefore considered indirectly controlled by DNB Bank ASA in accordance with the Securities Trading Act § 4-2 (consolidation rules) and the acquisition was triggered by enforcement of pledge as a result of a breach of loan terms related to a secured loan.·1 päivä sitten · MuokattuHere you have it in black and white. There will be a sell-off here- stay away DNB on Gentian shares: Normally not a long-term owner On Wednesday it became known that DNB has taken over the shares in investor Runar Vatne's equity investment company Vatne Equity. Through this company, Vatne was the largest owner in Gentian Diagnostics. These shares are now owned by DNB after the bank exercised a pledge. With this, DNB has become the largest shareholder in Gentian, but it is far from certain that it will remain so. – The bank normally does not have a strategy of being a long-term owner in such companies.
- 6.5.6.5.Expecting "org annonuncements" related to NT-proBT project failure.
- ·17.3. · MuokattuIs this heading up from a double bottom formation here now? The technical risk is arguably relatively low as the last bottoms were also at the level of previous support. In addition, it is fundamentally positive that the company has the financial capacity to pay dividends.
- ·19.2. · MuokattuGood to get a bit more turnover in the share, almost 4 million today is quite a lot for Gentian. Not just anyone either. Forced sale? Gentian Diagnostics: CTO buys shares, companies pull out today 10:50 AM ∙ News summary (AI) Gentian Diagnostics has recently experienced significant changes in its ownership structure. The company's Chief Technology Officer (CTO), Frank Frantzen, showed confidence by increasing his personal stake through a significant share purchase. At the same time, two investment companies, SKØIEN AS and DUKAT AS, are no longer listed among the company's shareholders, which indicates a sale of their holdings. CTO Frank Frantzen bought 3,115 shares in Gentian Diagnostics at an average price of NOK 40.0 per share. After this transaction, CTO Frank Frantzen now owns a total of 23,115 shares and 50,000 options in the company. The investment company SKØIEN AS has left the list of Gentian Diagnostics' shareholders. https://e24.no/boers-og-finans/i/kw2Q29/ny-smell-for-investor-tore-aksel-voldberg-selskapets-aksjekapital-er-tapt
- ·13.2.Not long ago, an analyst on Hegnar-TV highlighted this stock as the best case this year. The price was then at 58 kr.. I have at least bought some today.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 76 | - | - | ||
| 9 | - | - | ||
| 14 | - | - | ||
| 1 | - | - | ||
| 20 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 9.7. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
2025 Q4 -tulosraportti 11.2. | ||
2025 Q3 -tulosraportti 23.10.2025 | ||
2025 Q2 -tulosraportti 10.7.2025 | ||
2025 Q1 -tulosraportti 7.5.2025 |
2026 Q1 -tulosraportti
10 päivää sitten
‧54 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 9.7. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 6.5. | ||
2025 Q4 -tulosraportti 11.2. | ||
2025 Q3 -tulosraportti 23.10.2025 | ||
2025 Q2 -tulosraportti 10.7.2025 | ||
2025 Q1 -tulosraportti 7.5.2025 |
0,60 NOK/osake
Viimeisin osinko
1,01%Tuotto/v
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·3 päivää sittenUgh ugh- DnB as a major owner, shares they should not own, shares they are going to sell, shares forcibly taken from Vatne. This will be ugly Flagging notification Gentian Diagnostics DNB Bank ASA has taken over ownership of 100% of the shares in Vatne Equity AS, which as of May 12, 2026, owns 2,110,224 shares in Gentian Diagnostics ASA ("Gentian") The company's ownership interest and voting rights, corresponding to 13.65% of outstanding shares in Gentian, are therefore considered indirectly controlled by DNB Bank ASA in accordance with the Securities Trading Act § 4-2 (consolidation rules) and the acquisition was triggered by enforcement of pledge as a result of a breach of loan terms related to a secured loan.·1 päivä sitten · MuokattuHere you have it in black and white. There will be a sell-off here- stay away DNB on Gentian shares: Normally not a long-term owner On Wednesday it became known that DNB has taken over the shares in investor Runar Vatne's equity investment company Vatne Equity. Through this company, Vatne was the largest owner in Gentian Diagnostics. These shares are now owned by DNB after the bank exercised a pledge. With this, DNB has become the largest shareholder in Gentian, but it is far from certain that it will remain so. – The bank normally does not have a strategy of being a long-term owner in such companies.
- 6.5.6.5.Expecting "org annonuncements" related to NT-proBT project failure.
- ·17.3. · MuokattuIs this heading up from a double bottom formation here now? The technical risk is arguably relatively low as the last bottoms were also at the level of previous support. In addition, it is fundamentally positive that the company has the financial capacity to pay dividends.
- ·19.2. · MuokattuGood to get a bit more turnover in the share, almost 4 million today is quite a lot for Gentian. Not just anyone either. Forced sale? Gentian Diagnostics: CTO buys shares, companies pull out today 10:50 AM ∙ News summary (AI) Gentian Diagnostics has recently experienced significant changes in its ownership structure. The company's Chief Technology Officer (CTO), Frank Frantzen, showed confidence by increasing his personal stake through a significant share purchase. At the same time, two investment companies, SKØIEN AS and DUKAT AS, are no longer listed among the company's shareholders, which indicates a sale of their holdings. CTO Frank Frantzen bought 3,115 shares in Gentian Diagnostics at an average price of NOK 40.0 per share. After this transaction, CTO Frank Frantzen now owns a total of 23,115 shares and 50,000 options in the company. The investment company SKØIEN AS has left the list of Gentian Diagnostics' shareholders. https://e24.no/boers-og-finans/i/kw2Q29/ny-smell-for-investor-tore-aksel-voldberg-selskapets-aksjekapital-er-tapt
- ·13.2.Not long ago, an analyst on Hegnar-TV highlighted this stock as the best case this year. The price was then at 58 kr.. I have at least bought some today.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 76 | - | - | ||
| 9 | - | - | ||
| 14 | - | - | ||
| 1 | - | - | ||
| 20 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt